MedTrace Logo

Effects of a Synbiotics-containing Starter Formula on Infant Growth

NCT01010113 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 140

Last updated 2012-04-23

No results posted yet for this study

Summary

In this study the investigators want to evaluate the satiety of two infant formulas, one containing prebiotics and the other containing synbiotics. Rate of weight gain, a proxy measurement for the healthy development of an infant, will be assessed in both groups and compared to the growth observed in the WHO Child Growth Standards in order to demonstrate non inferiority.

Conditions

  • Infant Nutrition

Interventions

OTHER

Standard infant formula with prebiotics

From 0-6 months of age. As per standard requirement

OTHER

Infant formula with synbiotics

From 0-6 months of age as per standard requirement

Sponsors & Collaborators

  • National University Hospital, Singapore

    collaborator OTHER

  • Société des Produits Nestlé (SPN)

    lead INDUSTRY

Principal Investigators

  • Dr. Lee Le Ye, MD · National University Hospital, Singapore

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
11 Days
Max Age
17 Days
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-11-30
Primary Completion
2011-04-30
Completion
2011-06-30

Countries

  • Singapore

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01010113 on ClinicalTrials.gov